Selected research
Industry Research
Inhalation Preparation Industry Research Report 2026
Market perspective
The global Inhalation Preparation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Inhalation Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Inhalation Preparation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Inhalation Preparation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Inhalation Preparation include GSK, Boehringer-Ingelheim, AstraZeneca, Daphne Pharmaceutical, Hengrui Medicine, Joincare Pharmaceutical, Purity Pharmaceutical, Jewim Pharmaceutical and Sphsine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Inhalation Preparation market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Inhalation Preparation Market by Company
GSK
Boehringer-Ingelheim
AstraZeneca
Daphne Pharmaceutical
Hengrui Medicine
Joincare Pharmaceutical
Purity Pharmaceutical
Jewim Pharmaceutical
Sphsine
Xianju Pharmaceutical
CF PharmTech
CTTQ
Inhalation Preparation Segment by Type
Nebules Inhalation Solution (NEB)
Metered Dose Inhalers (MDI)
Spary
Dry Powder Inhalation (DPI)
Inhalation Preparation Segment by Application
Pulmonary Hypertension Treatment
COPD
Inhalation Anesthesia
Asthma
Others
Inhalation Preparation Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhalation Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Preparation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Inhalation Preparation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Inhalation Preparation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Inhalation Preparation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nebules Inhalation Solution (NEB)
- Metered Dose Inhalers (MDI)
- Spary
- Dry Powder Inhalation (DPI)
Applications
- Pulmonary Hypertension Treatment
- COPD
- Inhalation Anesthesia
- Asthma
- Others
Companies covered
- GSK
- Boehringer-Ingelheim
- AstraZeneca
- Daphne Pharmaceutical
- Hengrui Medicine
- Joincare Pharmaceutical
- Purity Pharmaceutical
- Jewim Pharmaceutical
- Sphsine
- Xianju Pharmaceutical
- CF PharmTech
- CTTQ
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Inhalation Preparation Market Size (2021-2032)
- 2.2.2 Global Inhalation Preparation Sales (2021-2032)
- 2.2.3 Global Inhalation Preparation Market Average Price (2021-2032)
- 2.3 Inhalation Preparation by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Nebules Inhalation Solution (NEB)
- 2.3.3 Metered Dose Inhalers (MDI)
- 2.3.4 Spary
- 2.3.5 Dry Powder Inhalation (DPI)
- 2.4 Inhalation Preparation by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pulmonary Hypertension Treatment
- 2.4.3 COPD
- 2.4.4 Inhalation Anesthesia
- 2.4.5 Asthma
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Inhalation Preparation Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Inhalation Preparation Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Inhalation Preparation Revenue of Manufacturers (2021-2026)
- 3.4 Global Inhalation Preparation Average Price by Manufacturers (2021-2026)
- 3.5 Global Inhalation Preparation Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Inhalation Preparation, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Inhalation Preparation, Product Type & Application
- 3.8 Global Manufacturers of Inhalation Preparation, Established Date
- 3.9 Global Inhalation Preparation Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Inhalation Preparation Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Boehringer-Ingelheim
- 4.2.1 Boehringer-Ingelheim Company Information
- 4.2.2 Boehringer-Ingelheim Business Overview
- 4.2.3 Boehringer-Ingelheim Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boehringer-Ingelheim Inhalation Preparation Product Portfolio
- 4.2.5 Boehringer-Ingelheim Recent Developments
- 4.3 AstraZeneca
- 4.3.1 AstraZeneca Company Information
- 4.3.2 AstraZeneca Business Overview
- 4.3.3 AstraZeneca Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 AstraZeneca Inhalation Preparation Product Portfolio
- 4.3.5 AstraZeneca Recent Developments
- 4.4 Daphne Pharmaceutical
- 4.4.1 Daphne Pharmaceutical Company Information
- 4.4.2 Daphne Pharmaceutical Business Overview
- 4.4.3 Daphne Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Daphne Pharmaceutical Inhalation Preparation Product Portfolio
- 4.4.5 Daphne Pharmaceutical Recent Developments
- 4.5 Hengrui Medicine
- 4.5.1 Hengrui Medicine Company Information
- 4.5.2 Hengrui Medicine Business Overview
- 4.5.3 Hengrui Medicine Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hengrui Medicine Inhalation Preparation Product Portfolio
- 4.5.5 Hengrui Medicine Recent Developments
- 4.6 Joincare Pharmaceutical
- 4.6.1 Joincare Pharmaceutical Company Information
- 4.6.2 Joincare Pharmaceutical Business Overview
- 4.6.3 Joincare Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Joincare Pharmaceutical Inhalation Preparation Product Portfolio
- 4.6.5 Joincare Pharmaceutical Recent Developments
- 4.7 Purity Pharmaceutical
- 4.7.1 Purity Pharmaceutical Company Information
- 4.7.2 Purity Pharmaceutical Business Overview
- 4.7.3 Purity Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Purity Pharmaceutical Inhalation Preparation Product Portfolio
- 4.7.5 Purity Pharmaceutical Recent Developments
- 4.8 Jewim Pharmaceutical
- 4.8.1 Jewim Pharmaceutical Company Information
- 4.8.2 Jewim Pharmaceutical Business Overview
- 4.8.3 Jewim Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jewim Pharmaceutical Inhalation Preparation Product Portfolio
- 4.8.5 Jewim Pharmaceutical Recent Developments
- 4.9 Sphsine
- 4.9.1 Sphsine Company Information
- 4.9.2 Sphsine Business Overview
- 4.9.3 Sphsine Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sphsine Inhalation Preparation Product Portfolio
- 4.9.5 Sphsine Recent Developments
- 4.10 Xianju Pharmaceutical
- 4.10.1 Xianju Pharmaceutical Company Information
- 4.10.2 Xianju Pharmaceutical Business Overview
- 4.10.3 Xianju Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Xianju Pharmaceutical Inhalation Preparation Product Portfolio
- 4.10.5 Xianju Pharmaceutical Recent Developments
- 4.11 CF PharmTech
- 4.11.1 CF PharmTech Company Information
- 4.11.2 CF PharmTech Business Overview
- 4.11.3 CF PharmTech Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CF PharmTech Inhalation Preparation Product Portfolio
- 4.11.5 CF PharmTech Recent Developments
- 4.12 CTTQ
- 4.12.1 CTTQ Company Information
- 4.12.2 CTTQ Business Overview
- 4.12.3 CTTQ Inhalation Preparation Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CTTQ Inhalation Preparation Product Portfolio
- 4.12.5 CTTQ Recent Developments
5 Global Inhalation Preparation Market Scenario by Region
- 5.1 Global Inhalation Preparation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Inhalation Preparation Sales by Region: 2021-2032
- 5.2.1 Global Inhalation Preparation Sales by Region: 2021-2026
- 5.2.2 Global Inhalation Preparation Sales by Region: 2027-2032
- 5.3 Global Inhalation Preparation Revenue by Region: 2021-2032
- 5.3.1 Global Inhalation Preparation Revenue by Region: 2021-2026
- 5.3.2 Global Inhalation Preparation Revenue by Region: 2027-2032
- 5.4 North America Inhalation Preparation Market Facts & Figures by Country
- 5.4.1 North America Inhalation Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Inhalation Preparation Sales by Country (2021-2032)
- 5.4.3 North America Inhalation Preparation Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Inhalation Preparation Market Facts & Figures by Country
- 5.5.1 Europe Inhalation Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Inhalation Preparation Sales by Country (2021-2032)
- 5.5.3 Europe Inhalation Preparation Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Inhalation Preparation Market Facts & Figures by Country
- 5.6.1 Asia Pacific Inhalation Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Inhalation Preparation Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Inhalation Preparation Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Inhalation Preparation Market Facts & Figures by Country
- 5.7.1 South America Inhalation Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Inhalation Preparation Sales by Country (2021-2032)
- 5.7.3 South America Inhalation Preparation Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Inhalation Preparation Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Inhalation Preparation Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Inhalation Preparation Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Inhalation Preparation Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Inhalation Preparation Sales by Type (2021-2032)
- 6.1.1 Global Inhalation Preparation Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Inhalation Preparation Sales Market Share by Type (2021-2032)
- 6.2 Global Inhalation Preparation Revenue by Type (2021-2032)
- 6.2.1 Global Inhalation Preparation Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Inhalation Preparation Revenue Market Share by Type (2021-2032)
- 6.3 Global Inhalation Preparation Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Inhalation Preparation Sales by Application (2021-2032)
- 7.1.1 Global Inhalation Preparation Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Inhalation Preparation Sales Market Share by Application (2021-2032)
- 7.2 Global Inhalation Preparation Revenue by Application (2021-2032)
- 7.2.1 Global Inhalation Preparation Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Inhalation Preparation Revenue Market Share by Application (2021-2032)
- 7.3 Global Inhalation Preparation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Inhalation Preparation Value Chain Analysis
- 8.1.1 Inhalation Preparation Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Inhalation Preparation Production Mode & Process
- 8.2 Inhalation Preparation Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Inhalation Preparation Distributors
- 8.2.3 Inhalation Preparation Customers
9 Global Inhalation Preparation Analyzing Market Dynamics
- 9.1 Inhalation Preparation Industry Trends
- 9.2 Inhalation Preparation Industry Drivers
- 9.3 Inhalation Preparation Industry Opportunities and Challenges
- 9.4 Inhalation Preparation Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst